MLAB · Mesa Laboratories Inc /Co/ · Documents
$127.08
+3.78 (+3.06%)
At close · Oct 20
View the 10-K filed Jun 3, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$690.00M
Shares
5.60M
Volume · Oct 20
51K
Avg daily vol (3M)
134.04K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-13 | 2026-10-12 | |
| 8-K | — | 2026-09-08 | — | |
| 8-K | — | 2026-08-10 | — | |
| 10-Q | — | 2026-08-10 | 2026-06-30 | |
| 8-K | — | 2026-07-30 | — | |
| DEF 14A | — | 2026-07-22 | 2026-09-08 | |
| 8-K | — | 2026-06-15 | 2026-06-11 | |
| 10-K | — | 2026-06-03 | 2026-03-31 | |
| 8-K | — | 2026-05-27 | — | |
| 8-K | — | 2026-03-23 | 2026-03-20 | |
| 8-K | — | 2026-03-09 | 2026-03-03 | |
| 10-Q | — | 2026-02-03 | 2025-12-31 | |
| 8-K | — | 2026-02-03 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-11-06 | — | |
| 8-K | — | 2025-08-25 | 2025-08-22 | |
| 8-K | — | 2025-08-18 | 2025-08-12 | |
| 10-Q | — | 2025-08-05 | 2025-06-30 | |
| 8-K | — | 2025-08-05 | — | |
| DEF 14A | — | 2025-07-11 | 2025-08-22 | |
| 8-K | — | 2025-06-06 | 2025-06-03 | |
| 8-K | — | 2025-05-28 | — | |
| 10-K | — | 2025-05-28 | 2025-03-31 | |
| 8-K | — | 2025-02-04 | — | |
| 10-Q | — | 2025-02-04 | 2024-12-31 | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-09-11 | 2024-09-06 | |
| 8-K | — | 2024-08-30 | — | |
| 8-K | — | 2024-08-05 | — | |
| 10-Q | — | 2024-08-05 | 2024-06-30 | |
| DEF 14A | — | 2024-07-19 | 2024-08-30 | |
| 10-K | — | 2024-06-28 | 2024-03-31 | |
| NT 10-K | — | 2024-06-14 | 2024-03-31 | |
| 8-K | — | 2024-06-05 | — | |
| 8-K | — | 2024-04-08 | 2024-04-05 | |
| 8-K | — | 2024-04-02 | 2024-04-01 | |
| 10-Q | — | 2024-02-05 | 2023-12-31 | |
| 8-K | — | 2024-02-05 | — | |
| 8-K | — | 2024-01-08 | 2024-01-05 | |
| 8-K | — | 2023-11-06 | — | |
| 10-Q | — | 2023-11-06 | 2023-09-30 | |
| 8-K | — | 2023-10-18 | 2023-10-16 | |
| 8-K | — | 2023-10-10 | 2023-10-05 | |
| 8-K | — | 2023-08-30 | — | |
| 8-K | — | 2023-08-25 | — | |
| 10-Q | — | 2023-08-03 | 2023-06-30 | |
| 8-K | — | 2023-08-03 | — | |
| DEF 14A | — | 2023-07-14 | 2023-08-25 | |
| PRE 14A | — | 2023-07-03 | 2023-08-25 |
Showing 1–50 of 114 filings
Key facts
CIK
724004
CUSIP
59064R109
13F (30d)
16 filings
16 filers
Visit website
Investor relations